Shawver Laura's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Apr 8, 2025
- Accession no.
- 0001415889-25-010395
- Filed
- Apr 8, 2025
- Trade date
- Apr 7, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $615.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shawver LauraCIK 0001551891 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Common Stock | MOption exerciseAcquired | +22,509 | $4.85 | +$109,168.65 | 232,855 | Direct | |
| Apr 7, 2025 | Common Stock | MOption exerciseAcquired | +27,493 | $4.85 | +$133,341.05 | 260,348 | Direct | |
| Apr 7, 2025 | Common Stock | SSaleDisposed | −50,002 | $12.30 | −$615,024.6 | 210,346 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Common Stock | MOption exerciseDisposed | −22,509 | $0.00 | $0 | 51,555 | Direct | |
| Apr 7, 2025 | Common Stock | MOption exerciseDisposed | −27,493 | $0.00 | $0 | 24,062 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.